SymBiosis Capital Partners, LLC: summary

SymBiosis Capital Partners, LLC reported 6 positions with a reported value of $52.77M in its 13F for Q1 2026. Compared with Q4 2025: 1 new positions, 6 exited.

Top positions

• Evommune Inc
• INVENTIVA SA
• WAVE LIFE SCIENCES LTD
• RANI THERAPEUTICS HLDGS INC
• CLENE INC
• SURROZEN INC